AI assistant
Sending…
NextCure, Inc. — Director's Dealing 2026
Feb 3, 2026
35069_dirs_2026-02-03_174105ab-a6bb-42d7-92f0-42a3620c8266.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NextCure, Inc. (NXTC)
CIK: 0001661059
Period of Report: 2026-01-30
Reporting Person: Richman Michael (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-01-30 | Employee Stock Option (Right to Buy) | $10.85 | A | 38190 | Acquired | 2036-01-29 | Common Stock (38190) | Direct |
Footnotes
F1: One fourth of the option vests on January 30, 2027. The remainder vests in 36 monthly installments beginning on February 28, 2027.
More from NextCure, Inc.
M&A Activity
2026
Jul 16
M&A Activity
2026
Jul 14
M&A Activity
2026
Jul 14
Board/Management Information
2026
Jun 25
Regulatory Filings
2026
Jun 1
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 12
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3